When was neumo founded?

neumo was founded in 2017 and raised its 1st funding round 9 years after it was founded.

Where is neumo located?

neumo is headquartered in Shibuya, Japan.

Is neumo a funded company?

neumo is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Apr 23, 2026.

When was the latest funding round of neumo?

neumo's latest funding was a $***** Series A round on Apr 23, 2026, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. Globally, the Biopharma Outsourcing sector has seen $1.28B in funding in 2026 to date.

Where does neumo rank among its competitors?

neumo ranks 1593rd amongst 1508 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was neumo, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of neumo?

neumo's top competitors include IntegriChain, Clinigen and CMIC HOLDINGS. Among them, neumo secured the most recent funding round in April, 2026.

neumo - 2026 Company Profile, Team, Funding & Competitors

neumo is a series A company based in Shibuya (Japan), founded in 2017 by Shinji Yamada. It operates as a Provider of diversified consulting services for biopharma sector. neumo has raised an undisclosed amount in funding. The company has 1508 active competitors, including 27 funded and 151 that have exited. Its top competitors include companies like IntegriChain, Clinigen and CMIC HOLDINGS.

Company Details

Website: neumo.jp
Social
Email ID: *****@neumo.jp

Key Metrics

Founded Year

2017

Location

Shibuya, Japan

Stage

Series A

Latest Funding Round

Series A, Apr 23, 2026, $*****

Investors

Ranked

1593^rd among 1769 competitors

Similar Companies

IntegriChain & 1767 more

View neumo's full profile

neumo has raised funding over 1 round. Its latest funding round was a Series A round on Apr 23, 2026 for $*****. 1 investor participated in its latest round. neumo has 1 institutional investor.

Here is the list of recent funding rounds of neumo:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 23, 2026	6742680	Series A	5318998	9916390	3253158	7755137

Access funding benchmarks and valuations. Sign up today!

View details of neumo's funding rounds and investors

The founders of neumo is Shinji Yamada. Ryusei Wakabayashi is the CEO of neumo.

Here are the details of neumo's key team members:

Shinji Yamada: Co-Founder of neumo.
Ryusei Wakabayashi: CEO of neumo.

View details of neumo's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of neumo include IntegriChain, Clinigen and CMIC HOLDINGS. Here is the list of Top 10 competitors of neumo, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	63/100
2nd	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
3rd	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
4th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Baird Capital, Intertrust & 8 others	56/100
5th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
6th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
7th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
8th	Sequence 2002, Morrisville (United States), Acquired	Consulting services provider	-	-	49/100
9th	Avalon Bio Ventures 1983, San Diego (United States), Unfunded	Venture capital firm and startup accelerator focused on life science companies	-	-	48/100
10th	Oxford PharmaGenesis 1998, Oxford (United Kingdom), Acquired	Provider of medical affairs, marketing, communication, consultancy, and other services for healthcare sector	-	-	48/100
1593rd	neumo 2017, Shibuya (Japan), Series A	Provider of diversified consulting services for biopharma sector	-	D3	15/100